Diferencia entre revisiones de «Valganciclovir»
(Created page with "==Administration== *Type: Antiviral *Dosage Forms: *Routes of Administration: Oral *Common Trade Names: ==Adult Dosing== *CMV infection: 900 mg PO BID *CMV prophylaxis:...") |
Sin resumen de edición |
||
| Línea 13: | Línea 13: | ||
==Special Populations== | ==Special Populations== | ||
*[[Drug pregnancy categories|Pregnancy Rating]]: | *[[Drug pregnancy categories|Pregnancy Rating]]: Category C, fetal risk cannot be ruled out | ||
*Lactation risk: infant risk cannot be ruled out | *Lactation risk: infant risk cannot be ruled out | ||
*Renal dosing | *Renal dosing | ||
| Línea 55: | Línea 55: | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
[[Category:ID]] | |||
Revisión actual - 23:23 23 sep 2019
Administration
- Type: Antiviral
- Dosage Forms:
- Routes of Administration: Oral
- Common Trade Names:
Adult Dosing
- CMV infection: 900 mg PO BID
- CMV prophylaxis: 900 mg PO daily
Pediatric Dosing
- Neonatal CMV infection: 17 mg/kg PO daily BID x 12 weeks, then 17 mg/kg daily until 1 year of age
Special Populations
- Pregnancy Rating: Category C, fetal risk cannot be ruled out
- Lactation risk: infant risk cannot be ruled out
- Renal dosing
- CrCl 40-59 mL/min: 450 mg BID
- CrCl 25-39 mL/min: 450 mg once daily
- CrCl 10-24 mL/min: 450 mg every 2 days
- CrCl < 10 mL/min or on HD: not recommended
- Hepatic dosing:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- Anemia/aplastic anemia, leukopenia, thrombocytopenia, pancytopenia
Common
- Nausea/vomiting, diarrhea
- Graft rejection
- Headache
- URI
- UTI
- Fever
- Tremor
Pharmacology
- Half-life: 4-10h
- Metabolism: Hepatic
- Excretion: Renal
Mechanism of Action
- Inhibits viral DNA synthesis